Delivery Order SPE2DB22D1106-SPE2DB25FDUC9
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,863.66 and is a delivery order for ORILISSA 150 MG TABLET 7S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D2001|SPE2DB23FM70E) valued at $13,309.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Orilissa 150 mg tablets with an ultimate completion date of August 25, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,635.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for the supply of a wide range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,837.85, is a firm fixed-price delivery order for the supply of the drug ORILISSA 150 MG TABLET 7S. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,947.84 firm fixed-price delivery order is for ORILISSA 150 MG tablets, a specialty medication. The contract has an ultimate completion date of October 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,313.57 for the supply of ORILISSA 150 MG TABLET 7S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distributor Amerisourcebergen Corporation. The $2,341.16 firm fixed price delivery order is for the supply of ORILISSA 200 MG TABLET 14S, a pharmaceutical product. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,354.31 firm fixed-price delivery order is for the medication ORILISSA 150 MG TABLET 7S, with a completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, spanning a wide range of pharmaceutical products and medical...
This federal contract award, valued at $3,548.90, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $19,598.95 firm-fixed-price delivery order covers the supply of ORILISSA 150MG TAB 28S, a pharmaceutical product, with a completion date of April 23, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...